Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoadjuvant Melanoma”

103 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 103 results

Testing effectiveness (Phase 2)UnknownNCT04248387
What this trial is testing

Toripalimab in the Neoadjuvant Treatment of BRAF V600 Wild Type Melanoma

Who this might be right for
Melanoma Stage IIIB-IV
Fudan University 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT02231775
What this trial is testing

Dabrafenib and Trametinib Before and After Surgery in Treating Patients With Stage IIIB-C Melanoma With BRAF V600 Mutation

Who this might be right for
Stage IIIB Cutaneous Melanoma AJCC v7Stage IIIC Cutaneous Melanoma AJCC v7
M.D. Anderson Cancer Center 58
Testing effectiveness (Phase 2)Study completedNCT04133948
What this trial is testing

Multicenter Phase 1b Trial Testing the Neoadjuvant Combination of Domatinostat, Nivolumab and Ipilimumab in IFN-gamma Signature-low and IFN-gamma Signature-high RECIST 1.1-measurable Stage III Cutaneous or Unknown Primary Melanoma

Who this might be right for
Malignant Melanoma Stage III
The Netherlands Cancer Institute 44
Testing effectiveness (Phase 2)Ended earlyNCT02303951
What this trial is testing

Neoadjuvant Vemurafenib + Cobimetinib + Atezolizumab in Melanoma: NEO-VC

Who this might be right for
Malignant Melanoma
University Hospital Tuebingen 47
Not applicableStudy completedNCT07091695
What this trial is testing

Real-world Outcomes Among Patients With Melanoma Treated With Neoadjuvant Nivolumab+Relatlimab or Nivolumab+Ipilimumab

Who this might be right for
Melanoma
Bristol-Myers Squibb 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT05081609
What this trial is testing

Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies

Who this might be right for
Advanced Solid TumorLocally Advanced Solid TumorMetastatic Solid Tumor+10 more
Ascendis Pharma Oncology Division A/S 320
Testing effectiveness (Phase 2)Active Not RecruitingNCT05187884
What this trial is testing

Neoadjuvant/Adjuvant Trial of Darovasertib in Ocular Melanoma

Who this might be right for
Ocular Melanoma
St Vincent's Hospital, Sydney 15
Early research (Phase 1)Study completedNCT02339324
What this trial is testing

Neoadjuvant Combination Biotherapy With Pembrolizumab and High Dose IFN-alfa2b

Who this might be right for
Melanoma
Yana Najjar 31
Testing effectiveness (Phase 2)Study completedNCT01341158
What this trial is testing

NAM-Trial: Multiferon in Malignant Melanoma

Who this might be right for
Locoregional Metastases in Malignant Melanoma Stages IIIB/C
University Hospital Tuebingen 42
Testing effectiveness (Phase 2)Study completedNCT00525031
What this trial is testing

Temozolomide Alone or With Pegylated Interferon-Alpha 2b (PGI) in Melanoma Patients

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 55
Not applicableStudy completedNCT00596362
What this trial is testing

Treatment With Intravitreal Avastin for Large Uveal Melanomas

Who this might be right for
Uveal Melanoma
Memorial Sloan Kettering Cancer Center 1
Testing effectiveness (Phase 2)UnknownNCT04622566
What this trial is testing

Lenvatinib and Pembrolizumab in Resectable Mucosal Melanoma

Who this might be right for
Mucosal MelanomaNeoadjuvant Treatment
Peking University Cancer Hospital & Institute 26
Large-scale testing (Phase 3)Active Not RecruitingNCT04949113
What this trial is testing

Neoadjuvant Ipilimumab Plus Nivolumab Versus Standard Adjuvant Nivolumab in Macroscopic Stage III Melanoma

Who this might be right for
Malignant Melanoma Stage III
The Netherlands Cancer Institute 423
Early research (Phase 1)Active Not RecruitingNCT06014086
What this trial is testing

Intratumoral PH-762 for Cutaneous Carcinoma

Who this might be right for
Squamous Cell Carcinoma of the SkinMalignant Melanoma of SkinMerkel Cell Carcinoma of Skin
Phio Pharmaceuticals Inc. 30
Testing effectiveness (Phase 2)WithdrawnNCT04007588
What this trial is testing

A Phase II Trial of Neoadjuvant Treatment With PD-1 Inhibition (Nivolumab) With or Without IDO Inhibition (BMS-986205) and With or Without CTLA-4 Inhibition (Ipilimumab) in Resectable Stage III or IV Melanoma

Who this might be right for
Melanoma Stage IIIMelanoma Stage IV
Dana-Farber Cancer Institute
Testing effectiveness (Phase 2)Ended earlyNCT04310397
What this trial is testing

Dabrafenib, Trametinib, and Spartalizumab for the Treatment of BRAF V600E or V600K Mutation Positive Stage IIIB/C/D Melanoma

Who this might be right for
Pathologic Stage IIIB Cutaneous Melanoma AJCC v8Pathologic Stage IIIC Cutaneous Melanoma AJCC v8Pathologic Stage IIID Cutaneous Melanoma AJCC v8
M.D. Anderson Cancer Center 4
Very early researchStudy completedNCT00972933
What this trial is testing

Immunogenicity and Biomarker Analysis of Neoadjuvant Ipilimumab for Melanoma

Who this might be right for
Melanoma
Diwakar Davar 59
Testing effectiveness (Phase 2)WithdrawnNCT03005639
What this trial is testing

ML29255 Neoadjuvant Vemurafenib and Cobimetinib Melanoma

Who this might be right for
Stage IIIB-C Melanoma
Inova Health Care Services
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07517653
What this trial is testing

Neoadjuvant SHR-1701 Plus Famitinib With Response-guided Adjuvant Therapy in Resectable Mucosal Melanoma

Who this might be right for
Melanoma
Shanghai Zhongshan Hospital 70
Testing effectiveness (Phase 2)Looking for participantsNCT06295159
What this trial is testing

Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma

Who this might be right for
Melanoma Stage IIIMelanoma Stage IVAdvanced Melanoma+1 more
H. Lee Moffitt Cancer Center and Research Institute 90
Load More Results